Sowell Financial Services LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1633697 NORTH LITTLE ROCK, AR

Position in HALO

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$850,873

+$175,942 QoQ

Shares Held

10,871

+4.1% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#324

of 661 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sowell Financial Services LLC holds $6,370,982 across 18 Biotechnology names. HALO ranks #2 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,930	$1,455,418
2	HALO	Halozyme Therapeutics, Inc. This page	10,871	$850,873
3	JAZZ	Jazz Pharmaceuticals plc	2,239	$539,531
4	LGND	Ligand Pharmaceuticals Inc	1,547	$488,991
5	RPRX	Royalty Pharma plc	7,456	$418,057
6	RXRX	Recursion Pharmaceuticals, Inc.	110,430	$405,278
7	ARGX	Argenx SE	365	$338,636
8	REGN	Regeneron Pharmaceuticals, Inc.	502	$313,017

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$850,873	10,871	+4.1%	Shares	Sole	2026-07-20
2026-03-31	$674,931	10,443	+14.1%	Shares	Sole	2026-04-20
2025-12-31	$616,064	9,154	+0.8%	Shares	Sole	2026-01-21
2025-09-30	$665,927	9,080	+235.8%	Shares	Sole	2025-10-17
2021-03-31	$112,729	2,704	-26.9%	Shares	Sole	2021-05-07
2020-12-31	$157,898	3,697	-11.5%	Shares	Sole	2021-01-13
2020-09-30	$109,824	4,179	-35.7%	Shares	Sole	2020-11-12
2020-06-30	$174,211	6,498	+655.6%	Shares	Sole	2020-08-13
2020-03-31	$15,471	860	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.